CC(=O)N1CCN(C(=O)c2ccc(Cl)c(S(=O)(=O)N3CC(C)OC(C)C3)c2)CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?